Cipla shares rise on cancer drug licensing deal with Sino Biopharma arm
Cipla shares gained after it inked a cancer treatment drug licensing deal with Sino Biopharma’s arm.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.